Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
xuezhitong jiaonang
- Development stage
- Unknown
- Lead developer
- Jilin Oriental Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Xuezhi Tong Capsules (血滞通胶囊) is a Traditional Chinese Medicine (TCM) product developed and manufactured by Jilin Province Oriental Pharmaceutical. The formulation is primarily composed of an extract from *Allium macrostemon* Bunge (Xiebai). It is indicated for the treatment of hyperlipidemia, particularly in patients exhibiting TCM syndromes of phlegm-stasis resistance. The therapeutic mechanism involves activating blood circulation, resolving phlegm, and dredging collaterals, which collectively help to lower elevated serum cholesterol and triglycerides. By improving lipid metabolism and blood flow, it is used to manage blood circulation disorders and potentially mitigate the progression of atherosclerosis. It is an oral medication approved for marketing in China.
- Brand names
- Xuezhi Tong血滞通
- Other names
- Xuezhi Tong Capsules血滞通胶囊Xuezhitong Jiaonang
02
Targets
HMOX1 (Heme oxygenase 1)GPX1 (Glutathione peroxidase 1)HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)MAPK3 (Mitogen-activated protein kinase 1)DGAT2 (Hepatic diacylglycerol acyltransferase 2)NOX4 (NADPH oxidase 4)SREBP-1 / SREBF1 (SREBP-1)
Beyond the preview
Go deeper on xuezhitong jiaonang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on xuezhitong jiaonang.